Identification of genetic association between mitochondrial dysfunction and knee osteoarthritis through integrating multi-omics: a summary data-based Mendelian randomization study
Association between mitochondrial dysfunction and osteoarthritis (OA) has been consistently investigated, yet their genetic association remains obscure. In this study, mitochondrial-related genes were used as instrumental variables to proxy for mitochondrial dysfunction, and summary data of knee OA (KOA) were used as outcome to examine their genetic association.
Methods
We obtained 1136 mitochondrial-related genes from the human MitoCarta3.0 database. Genetic proxy instruments for mitochondrial-related genes from studies of corresponding gene expression (n = 31,684) and protein (n = 35,559) quantitative trait locus (eQTLs and pQTLs), respectively. Aggregated data for KOA (62,497 KOA cases and 333,557 controls) were extracted from the largest OA genome-wide association study (GWAS). We integrated QTL data with KOA GWAS data to estimate their genetic association using summary data-based Mendelian randomization analysis (SMR). Additionally, we implemented Bayesian colocalization analysis to reveal whether suggestive mitochondrial-related genes and KOA were driven by a same genetic variant. Finally, to validate the primary findings, replication study (24,955 cases and 378,169 controls) and multi-SNP-based SMR (SMR-multi) test was performed.
Results
Through SMR analysis, we found that the expression levels of 2 mitochondrial-related genes were associated with KOA risk. Specifically, elevated gene expression levels of the IMMP2L (odds ratio [OR] = 1.056; 95% confidence interval [CI] = 1.030–1.082; P-FDR = 0.004) increased the risk of KOA. Conversely, increased gene expression levels of AKAP10 decreased the risk of KOA (OR = 0.955; 95% CI, 0.934–0.977; P-FDR = 0.019). Colocalization analysis demonstrated that AKAP10 (PP.H4 = 0.84) and IMMP2L (PP.H4 = 0.91) shared the same genetic variant with KOA. In addition, consistent results were found in replication study and SMR-multi test, further demonstrating the reliability of our findings.
Conclusions
In summary, our analyses revealed the genetic association between mitochondrial dysfunction proxied by mitochondrial-related genes and KOA, providing new insight into potential pathogenesis of KOA. Furthermore, these identified candidate genes offer the possibility of clinical drug target development for KOA.
Key points
• This is the first SMR study to explore the genetic association between mitochondrial dysfunction proxied by mitochondrial-related genes and KOA.
• Sufficient evidence to support genetic association between the expression levels of AKAP10 and IMMP2L, and KOA
• Our MR analysis may provide novel new insight into potential pathogenesis of KOA.
• These identified candidate genes offer the possibility of clinical drug target development for KOA
Jiale Xie and Rui Ma contributed equally to this work.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Introduction
Knee osteoarthritis (KOA) is a common musculoskeletal disease among middle-aged and elderly individuals, characterized by chronic pain and functional disability [1]. It involves pathological changes in all joint tissues, including synovitis, cartilage extracellular matrix degradation, chondrocyte apoptosis, subchondral bone sclerosis, and osteophyte formation [2]. Globally, KOA accounts for approximately 80% of all OA cases. The onset of KOA symptoms peaks between the ages of 55 and 64, and the prevalence increases with age, significantly impacting patients’ quality of life and well-being [3, 4]. Although previous studies have investigated various aspects of the pathogenesis of KOA, such as abnormal mechanical load, oxidative stress, inflammatory factors, and mitochondrial dysfunction, the underlying mechanism is not fully understood [5]. Therefore, further research is necessary to deepen our understanding of the pathogenesis of KOA.
Mitochondria serve as the primary sites of energy production in eukaryotic cells and generate adenosine triphosphate (ATP) through oxidative phosphorylation. Additionally, mitochondria play crucial roles in various cellular functions, such as oxidative stress, biosynthesis and metabolism, and intercellular communication [6]. These highly dynamic cellular organelles continuously reshape their morphology through fusion and fission to adapt their functions. When mitochondrial dynamics are imbalanced, mitochondrial dysfunction occurs, leading to cell degeneration or death [7]. KOA is characterized by chondrocyte damage influenced by multiple factors, with aging closely related to its development. Mitochondrial dysfunction is an important marker of cell aging. Ageing-related mitochondrial dysfunction damages cartilage by releasing reactive oxygen species (ROS), leading to the progression of KOA [8]. During mitochondrial dysfunction, excessive ROS accumulation inhibits the oxidation of cysteine to cysteine sulfinic acid (Cys-SO2H) or sulfonic acid (Cys-SO3H), thereby accelerating disease progression by damaging cellular pathways [9]. Substantial evidence has shown that mitochondrial autophagy is involved in KOA pathogenesis. Impaired mitochondrial autophagy results in excessive ROS accumulation, contributing to KOA [10]. Jiang et al. found that Cpt1a knockout regulated the aging phenotype of chondrocytes through PINK1-mediated mitophagy [11]. Liu et al. found that alpha-ketoglutarate (alpha-KG) significantly improved mitochondrial respiration in chondrocytes, enhanced mitochondrial autophagy, and delayed articular cartilage degeneration [12]. Moreover, numerous studies have shown that mitochondrial-related genes, such as monoamine oxidase B (MAOB) and mitochondrial protein mitofusin 2 (MFN2), are related to cell aging and OA [13, 14]. In addition to the 37 key mitochondrial genes, the associated genome contained more than 1000 additional nuclear genes. The susceptibility of these genes indicated that the mitochondria are easily affected by external environmental factors [15]. Mitochondrial dysfunction is a complex process. Although the promotion of KOA by mitochondrial dysfunction has been extensively studied, the specific mechanism remains unclear, necessitating further research.
Anzeige
Mendelian randomization (MR) is a novel method, which uses genetic variations as instrumental variables (IVs) to offer inferences regarding the causal relationships between exposures and outcomes. Compared with randomized controlled trials (RCTs), it can effectively eliminate the interference of confounding factors and reverse causation, resulting in greatly improved accuracy and credibility of results [16]. As an extension of the MR analysis, summary data-based MR (SMR) method was developed to facilitate the inference of genetic association between diverse molecular traits (e.g., gene expression, DNA methylation, or protein abundance) and diseases of interest [17]. Compared with traditional MR analyses, SMR, using the top cis-quantitative trait loci (QTL) as the exposure, can yield higher statistical power when the exposure and outcome are obtained from two independent samples with large sample sizes [17]. Notably, in recent years, as large-scale genome-wide association study (GWAS) and molecular QTL data continue to be explored, we have opportunity to integrate them to explore susceptibility risk genes for different diseases. Up to now, limited SMR studies had identified the potential genetic association between mitochondrial dysfunction and KOA. Therefore, this study aimed to explore the genetic relationship between mitochondrial dysfunction proxied by mitochondrial-related genes and KOA using multi-omics data (including gene expression (eQTL) and protein QTL (pQTL)) data.
Materials and methods
Ethical considerations
Data used in our study were publicly available, and further ethical approval was not required.
Study design
Figure 1 illustrates the study design and workflow. Initially, we obtained 1,136 mitochondrial-related genes from the human MitoCarta3.0 database [18]. Then, IVs of the mitochondrial-related genes extracted from eQTLs and pQTLs were used as proxies for mitochondrial dysfunction. Their association with KOA was investigated through SMR analysis. Additionally, to improve the reliability of the results, we performed the Heterogeneity in the dependent Instruments (HEIDI) test and Bayesian colocalization analysis. Only mitochondrial-related genes that passed the HEIDI test and colocalization analysis were considered candidate genes for KOA. In present study, summarized KOA GWAS data from the Genetics of Osteoarthritis (GO) Consortium were used as the primary discovery study, and to validate our findings, summarized KOA GWAS data from the UK Biobank and Arthritis Research UK Osteoarthritis Genetics (arcOGEN) Consortium were used as the replication study. Finally, we used the multi-SNP-based SMR (SMR-multi) test to further strengthen the genetic association of the identified candidate genes with KOA.
Fig. 1
Overview of the study design. IVs, instrumental variables; QTL, quantitative trait loci; MR, Mendelian randomization; OA, osteoarthritis
The eQTL IVs of mitochondrial-related genes were sourced from the eQTLGen Consortium, which identified 16,989 cis-eQTL genes in 31,684 blood samples [19]. Gene expression probes corresponding to cis-eQTLs located within 1 Mb of the gene center distance and detected in more than one cohort (false discovery rate (FDR) < 0.05) were included (www.eqtlgen.org/cis-eqtls.html). The pQTL IVs of the mitochondrial-related genes were extracted from a large-scale proteomics-wide association study by Ferkingstad et al., which measured 4,907 plasma proteins in 35,559 individuals of European descent [20]. In the present study, cis-pQTLs that reached the P < 5 \(\times\) 10–8 threshold and were within 1 Mb of their corresponding genes were selected.
Anzeige
Considering the tissue specificity of gene expression, we applied specific eQTL data from musculoskeletal tissues to strengthen the association of the identified candidate genes with KOA and reveal the deeper pathogenesis of KOA. Musculoskeletal tissue-specific eQTL IVs of mitochondrial-related genes were derived from the Genotype-Tissue Expression (GTEx) Consortium (n = 706) [21]. In this study, 49 human tissues were sequenced. Additionally, only cis-eQTLs were within 1 Mb of the transcription start site were selected.
Aggregated KOA GWAS data for discovery study were obtained from the largest GWAS meta-analysis of OA, comprising 13 international cohorts and 826,690 individuals. This study analyzed 11 common OA sites, and the summary data for KOA included 396,054 individuals (62,497 cases and 333, 557controls) [22]. To validate our findings, we used different KOA GWAS data (24,955 cases and 378,169 controls) provided by the UK Biobank and arcOGEN Consortium for the replication study [23]. More data information was presented in Supplementary Table 1.
Statistical analysis
We used SMR analysis to explore the genetic relationship between mitochondrial dysfunction proxied by mitochondrial-related genes and KOA. In the current SMR analysis, the most significant associated top cis-QTLs of mitochondrial-related genes were selected as IVs. Notably, when specific mitochondrial-related genes had multiple most significant cis-QTLs in the QTLs data (i.e., the p-values were the same), the cis-QTL with the largest absolute value of the Z-score was selected as the top cis-QTL. Additionally, we checked the consistency of allele frequency of each SNP between pairwise datasets, including QTL data, GWAS data, and LD reference data. SNPs with allele frequency differences < 0.20 between any pair of the data sets were included. Furthermore, to minimize bias caused by pleiotropy, the HEIDI test was rationally employed. Of note, a P-value of HEIDI > 0.05 suggested no pleiotropy, implying that the result was reliable [24]. Finally, we used FDR correction to avoid false genetic association. Only mitochondrial-related cis-QTLs that passed FDR correction (P _SMR corrected by FDR < 0.05) and HEIDI test (P _HEIDI > 0.05) were allowed to undergo further colocalization analyses. Notably, we additionally obtained eQTL data from musculoskeletal tissue to validate the primary results and provide further insights into the pathogenesis of KOA. Both SMR analysis and HEIDI tests were performed using SMR software for Windows version 1.3.1.
To avoid the bias induced by weak IV, we additionally calculated the F-statistics of the IVs of the candidate mitochondrial-related genes. Of note, an F-statistic of > 10 for IV indicated that it was valid and plausible. F-statistics were calculated by the following formula: F = R2 (N − 2)/(1 − R2) [25].
Bayesian colocalization analysis
To strengthen association evidence, we performed Bayesian colocalization analysis between mitochondrial-related cis-QTL meeting the above requirements (P_SMR-FDR correction < 0.05 and P _HEIDI > 0.05) and KOA using “coloc” package (version 5.2.3) in R software. And 1 Mb around the leading SNP was selected as colocalization region. The method of Bayesian colocalization can elucidate the possibility of shared genetic variation between two traits by presenting posterior probabilities for five hypotheses. In this study, we focused only on the posterior probabilities of Hypothesis 4 (PP.H4). Specifically, PP.H4 implied that the two traits were shared within the genetic region and were driven by the same variant. Here, we consider PP.H4 > 0.8 as the threshold for successful colocalization [26, 27].
SMR-multi test
We further performed the SMR-multi test to strengthen the genetic association between the identified candidate mitochondrial-related genes and KOA as it considers all SNPs in a cis-QTL region [28]. First, all cis-eQTL SNPs that were located within 500 kb of the top-associated cis-eQTL and reached the P < 5 \(\times\) 10–8 threshold were selected. Subsequently, those of them that passed the LD-square threshold (The default value is 0.1) were retained for final analysis. In addition, we checked the consistency of allele frequency of each SNP between pairwise datasets, including eQTL data, GWAS data, and LD reference data. SNPs with allele frequency differences < 0.20 between any pair of the data sets were included.
Positive control study
To increase the credibility of the study and the SMR method, a positive control analysis was performed. Since the accelerating effect of Runt-related transcription factor 2 (RUNX2) on the development of OA is well-established [29‐32], we thus investigated the association between RUNX2 expression levels and KOA as a positive control study for the SMR method.
Results
Mitochondrial-related gene expression and KOA
We identified a total of 864 mitochondrial-associated genes from the eQTL consortium (Supplementary Table 2). After FDR correction, four genes were found to be associated with KOA risk. Specifically, elevated gene expression levels of ubiquinol-cytochrome c reductase complex assembly factor 1 (OR = 1.160; 95% CI, 1.123–1.197; P-FDR = 4.45 \(\times\) 10–17)(UQCC1), mitochondrial calcium uptake 1 (OR = 1.152; 95% CI, 1.083–1.226; P-FDR = 0.003) (MICU1), and inner mitochondrial membrane peptidase subunit 2 (OR = 1.056; 95% CI, 1.030–1.082; P-FDR = 0.004) (IMMP2L) increased the risk of KOA, whereas decreased gene expression levels of A-kinase anchoring protein 10 (AKAP10) increased the risk of KOA (OR = 0.955; 95% CI, 0.934–0.977; P-FDR = 0.019) (Fig. 2). Notably, the F-statistics of the respective top SNPs selected for these four candidate genes are all over 10, indicating that our results are not affected by weak IVs (Supplementary Table 2). However, unfortunately, the association of UQCC1 and MICU1 (P _HEIDI < 0.05) with KOA was driven by pleiotropy (p_HEIDI test < 0.05) (Table 1). Furthermore, colocalization analysis demonstrated that AKAP10 (PP.H4 = 0.84) and IMMP2L (PP.H4 = 0.91) shared the same genetic variants with KOA (Table 1, Fig. 3), suggesting robust genetic association.
Fig. 2
SMR results for the genetic association between mitochondrial gene expression and knee osteoarthritis is presented in forest plot
Results of HEIDI test and colocalization analysis for the association between mitochondrial gene expression and knee osteoarthritis
Gene
SNP
Chr
Pos
p_HEIDI test
nsnp_HEIDI
PP.H4
UQCC1
rs4911178
20
33,952,620
0.002
20
MICU1
rs12779570
10
74,177,771
0.001
20
AKAP10
rs203477
17
19,831,819
0.461
20
0.84
IMMP2L
rs37759
7
110,934,682
0.186
20
0.91
SNP Single-nucleotide polymorphism, HEIDI Heterogeneity in the dependent Instruments, PP.H4 Posterior probabilities of hypothesis 4
Fig. 3
Locuscompare plot of Bayesian colocalization analysis for knee osteoarthritis and the expression of (A) AKAP10, (B) IMM2PL, (C) AKAP10 (GTEx consortium), and (D) IMM2PL (GTEx consortium)
Consistent with our primary findings in discover study, our replication study similarly showed that genetically predicted expression levels of AKAP10 were associated with a decreased risk of KOA (OR = 0.962; 95% CI, 0.934–0.992; P-value = 0.012), whereas expression levels of IMMP2L were associated with an increased risk of KOA (OR = 1.034; 95% CI, 1.001–1.068; P-value = 0.041) (Supplementary Table 4), which suggested the reliability of our results.
Mitochondrial-related protein abundance and KOA
A total of 107 mitochondrial-associated proteins were matched to the GWAS summary data reported by Ferkingstad et al. However, no proteins were observed to be associated with the risk of KOA after FDR correction (Supplementary Table 3). This might be attributed to 1) incomplete development of pQTL data and 2) fewer proteins have cis-pQTLs that meet the requirements for performing SMR analysis.
Mitochondrial-related gene expression in musculoskeletal tissues and KOA
Considering the tissue specificity of gene expression, we applied specific eQTL data from musculoskeletal tissues to strengthen the association between the identified candidate genes and KOA and reveal the deeper pathogenesis of KOA. Notably, AKAP10 (OR = 0.829; 95% CI, 0.743–0.926; P = 8.78 \(\times\) 10–04) and IMMP2L (OR = 1.213; 95% CI, 1.096–1.343; P = 1.98 \(\times\) 10–04) were also found to be associated with KOA in musculoskeletal tissues (Table 2). In addition, HEIDI test showed no pleiotropy between them (p_HEIDI test > 0.05) (Table 2). Further colocalization analyses were consistent with the primary findings (AKAP10 (PP.H4 = 0.81); IMMP2L (PP.H4 = 0.93)) (Table 2, Fig. 3).
Table 2
SMR results for association between musculoskeletal tissue-specific gene expression and knee osteoarthritis
Gene
Pos
SNP
OR (95CI)
p_SMR
p_HEIDI test
PP.H4
AKAP10(GTEx)
17
rs175922
0.829 (0.743–0.926)
8.78E-04
0.684
0.81
IMMP2L(GTEx)
7
rs214455
1.213 (1.096–1.343)
1.98E-04
0.210
0.93
GTEx Genotype-tissue expression, SNP Single-nucleotide polymorphism, OR Odds ratio, CI Confidence interval, SMR summary data-based Mendelian Randomization, HEIDI Heterogeneity in the dependent Instruments, PP.H4 Posterior probabilities of hypothesis 4
Results of SMR-multi test
A total of 1,879 eQTL SNPs significantly associated (P < 5 × 10–8) with AKAP10 expression and 1,687 eQTL SNPs significantly associated (P < 5 × 10–8) with IMMP2L expression were identified within their respective cis regions. However, only 59 cis-eQTL SNPs for AKAP10 and 51 cis-eQTL SNPs for IMMP2L passed the LD-square threshold 0.1 to be finally retained for SMR-multi test. As we expected, further SMR-multi test similarly showed that expression levels of IMMP2L were positively associated with the risk of KOA (P-value = 0.003), whereas expression levels of AKAP10 were negatively associated with the risk of KOA (P-value = 0.023) (Supplementary Table 5).
Anzeige
Results of positive control study
Positive control study showed that high expression levels of RUNX2 were associated with an increased risk of KOA (OR = 1.040; 95% CI, 1.006–1.075; P-value = 0.021) (Supplementary Table 6), suggesting the efficacy of the SMR method. Subsequent HEIDI test suggested that the association of RUNX2 expression levels with KOA (p_HEIDI test = 0.494) was not driven by pleiotropy (Supplementary Table 6).
Discussion
Using large-scale QTL data and GWAS summary data, we performed SMR analysis to examine the association of genetically proxied mitochondrial dysfunction with KOA risk. By combining SMR analysis and HEIDI test, the expression levels of 2 mitochondrial-related gene were found to be associated with KOA risk. Specifically, elevated gene expression levels of IMMP2L increased the risk of KOA, whereas increased gene expression levels of AKAP10 decreased the risk of KOA. Colocalization analysis demonstrated that AKAP10 and IMMP2L shared the same genetic variant with KOA. Additionally, consistent results were found in replication study, musculoskeletal tissues, and SMR-multi test, further suggesting the reliability of our findings and revealing the important role of mitochondrial dysfunction mediated by these genes in the pathogenesis of KOA.
AKAP10 gene, located on human chromosome 17, encodes a multi subunit protein that binds to the regulatory subunit of protein kinase A (PKA) [33]. Previous studies confirmed its important role in humans [34]. In recent decades, genetic variants of AKAP10 have been associated with cardiac arrhythmias[35], breast cancer[36], and preterm birth [37]. However, limited reports exist on the relationship between AKAP10 and OA. In the present study, we found that increased AKAP10 expression was associated with a reduced risk of KOA. The association can be reasonably explained through two possible mechanisms. First, AKAP10 contributes to the cholinergic/vagal signaling pathway and increases vagal sensitivity [35]. Notably, the presence of cholinergic nerves in most joint tissues, such as cartilage and subchondral bone, has been well described in a systematic review [38]. Some studies have found that vagus nerve activation can inhibit the production of cytokines (e.g., tumor necrosis factor (TNF), which may ameliorate joint inflammation [39]. Nicotine, an exogenous stimulator of the cholinergic system, has been shown to alleviate OA pain and slow cartilage degradation induced by sodium iodoacetate in mice [40]. Several in vitro tests have suggested that treatment with acetylcholinesterase inhibitors prevents cartilage degeneration and inflammation [41, 42]. Second, Kim et al. demonstrated that AKAP10 increased lipopolysaccharide-induced nitric oxide (NO) production [43]. NO, present in almost all types of human cells, has been shown to potentially have a protective effect on chondrocytes [44]. Surprisingly, NO was found to potentially relieve OA-related pain through blood flow, neurotransmitter pathways, opioid receptor pathways, and anti-inflammatory pathways [45]. Early subchondral bone loss and advanced subchondral bone sclerosis are important pathologic characteristics of OA [46, 47]. Therefore, the inhibition of excessive bone resorption mediated by osteoclasts in the early stages and abnormal bone formation mediated by osteoblasts in the late stages are currently the main therapeutic strategies of interest [48]. An older study by MacIntyre et al. revealed that NO inhibits the proliferation of osteoclasts and bone resorption in mice [49]. Many subsequent studies have found similar results [50, 51]. Notably, high concentrations of NO produced by NO donors or pro-inflammatory factors have been shown to be effective in inhibiting osteoblast growth and differentiation [52, 53]. Taken together, AKAP10 may slow the progression of OA by promoting the cholinergic/vagal nervous system and NO production.
IMMP2L encodes a protein responsible for cleaving signal peptide sequences of cytochrome c1 (CYC1) and mitochondrial glycerophosphate dehydrogenase 2 (GPD2) [54]. IMMP2L has previously been investigated in relation to ovarian aging [55] and autism[56]; however, limited research has been conducted on its association with KOA. Our results provide evidence that IMMP2L is a risk factor for KOA. Consistent with our findings, Lawther et al. recently observed decreased ROS in IMMP2L knockout mice [57]. Considering the close relationship between KOA and ROS, this finding appears plausible. More mechanisms underlying IMMP2L-induced KOA remain to be investigated.
Anzeige
The primary strength of our study is that we used a MR design, which diminished the bias resulting from confounders and reverse causality of traditional observational studies. In addition, evidence for genetic association was further strengthened by the success of colocalization analysis and HEIDI test. More importantly, consistent results were observed in replication study, musculoskeletal tissues, and SMR-multi test, suggesting the reliability of our findings. However, there are still several limitations. First, although the GWAS summary data for KOA in discover study we used were largest available, participants involved in this study were not exclusively of European ethnicity. It may lead to some bias. Surprisingly, fewer than 3% of the participants were of non-European ancestry; thus, we believe that the results remain robust. Second, there was a certain unmeasurable sample overlap that existed between the KOA GWAS datasets used in the primary and replication studies. It is caused by the inherent limitations of the development and updating of GWASs, as majority of the current large OA GWASs have been expanded and updated by adding new cohorts to the original data [22, 23, 58, 59]. Thus, we had to acknowledge this limitation that cannot be mitigated. In addition, probably due to the pQTL data have not been fully exploited yet, we failed to investigate any mitochondrial-related proteins associated with KOA. We expect more researchers to follow up with further exploration of pQTL data. Furthermore, the candidate genes we identified for KOA have small effect size and need to be carefully considered in clinical application. Finally, there were no available independent GWAS summary data that directly represent mitochondrial dysfunction, so we used genetically predicted mitochondrial-related genes to represent it.
Conclusion
In summary, our SMR and colocalization analyses examined the genetic association between mitochondrial dysfunction proxied by mitochondrial-related genes and KOA and revealed the important role of mitochondrial dysfunction mediated by these genes in the pathogenesis of KOA. Furthermore, these identified candidate genes offer the possibility of clinical drug target development for KOA. Further research was needed to validate our findings.
Acknowledgements
The authors acknowledge the contribution of Zhang et al. to the development of SMR algorithm and tools. The authors thank the participants and investigators of all the public database.
Compliance with ethical standards
Disclosures
None.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Unsere Produktempfehlungen
e.Med Interdisziplinär
Kombi-Abonnement
Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag
Mit e.MedInterdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.
Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.
Identification of genetic association between mitochondrial dysfunction and knee osteoarthritis through integrating multi-omics: a summary data-based Mendelian randomization study
Verfasst von
Jiale Xie
Rui Ma
Xin Xu
Mingyi Yang
Hui Yu
Xianjie Wan
Ke Xu
Junfei Guo
Peng Xu
Jang S, Lee K, Ju J H (2021) Recent Updates of Diagnosis, Pathophysiology, and Treatment on Osteoarthritis of the Knee. International journal of molecular sciences 22, https://doi.org/10.3390/ijms22052619.
3.
Vos T et al (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (London, England) 388:1545–1602. https://doi.org/10.1016/s0140-6736(16)31678-6CrossRef
4.
Losina E, Weinstein AM, Reichmann WM, Burbine SA, Solomon DH, Daigle ME, Rome BN, Chen SP, Hunter DJ, Suter LG et al (2013) Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US. Arthritis Care Res 65:703–711. https://doi.org/10.1002/acr.21898CrossRef
5.
Jiang W, Chen H, Lin Y, Cheng K, Zhou D, Chen R, Song C, Zeng L, Yu H (2023) Mechanical stress abnormalities promote chondrocyte senescence - The pathogenesis of knee osteoarthritis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 167:115552 https://doi.org/10.1016/j.biopha.2023.115552.
Gao Y, Guo L, Wang F, Wang Y, Li P, Zhang D (2024) Development of mitochondrial gene-editing strategies and their potential applications in mitochondrial hereditary diseases: a review. Cytotherapy 26:11–24. https://doi.org/10.1016/j.jcyt.2023.10.004CrossRefPubMed
An F, Zhang J, Gao P, Xiao Z, Chang W, Song J, Wang Y, Ma H, Zhang R, Chen Z et al (2023) New insight of the pathogenesis in osteoarthritis: the intricate interplay of ferroptosis and autophagy mediated by mitophagy/chaperone-mediated autophagy. Frontiers in cell and developmental biology 11:1297024. https://doi.org/10.3389/fcell.2023.1297024CrossRefPubMedPubMedCentral
11.
Jiang N, Xing B, Peng R, Shang J, Wu B, Xiao P, Lin S, Xu X, Lu H (2022) Inhibition of Cpt1a alleviates oxidative stress-induced chondrocyte senescence via regulating mitochondrial dysfunction and activating mitophagy. Mech Ageing Dev 205:111688. https://doi.org/10.1016/j.mad.2022.111688CrossRefPubMed
Bi S, Han B, Fan H, Liu Y, Cui X (2023) Mitochondria-Related Gene MAOB is a Key Biomarker of Osteoarthritis and Inhibition of Its Expression Reduces LPS-induced Chondrocyte Damage. Biochem Genet. https://doi.org/10.1007/s10528-023-10486-7CrossRefPubMed
14.
Xu L, Wu Z, He Y, Chen Z, Xu K, Yu W, Fang W, Ma C, Moqbel SAA, Ran J et al (2020) MFN2 contributes to metabolic disorders and inflammation in the aging of rat chondrocytes and osteoarthritis. Osteoarthritis Cartilage 28:1079–1091. https://doi.org/10.1016/j.joca.2019.11.011CrossRefPubMed
Xie N, Xie J, Wang Z, Shu Q, Shi H, Wang J, Liu N, Xu F, Wu J (2022) The Role of Calcium, 25-Hydroxyvitamin D, and Parathyroid Hormone in Irritable Bowel Syndrome: A Bidirectional Two-Sample Mendelian Randomization Study. Nutrients 14 https://doi.org/10.3390/nu14235109.
17.
Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, Montgomery GW, Goddard ME, Wray NR, Visscher PM et al (2016) Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet 48:481–487. https://doi.org/10.1038/ng.3538CrossRefPubMed
18.
Rath S, Sharma R, Gupta R, Ast T, Chan C, Durham TJ, Goodman RP, Grabarek Z, Haas ME, Hung WHW et al (2021) MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res 49:D1541–D1547. https://doi.org/10.1093/nar/gkaa1011CrossRefPubMed
19.
Võsa U, Claringbould A, Westra H-J, Bonder MJ, Deelen P, Zeng B, Kirsten H, Saha A, Kreuzhuber R, Yazar S et al (2021) Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet 53:1300–1310. https://doi.org/10.1038/s41588-021-00913-zCrossRefPubMedPubMedCentral
20.
Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, Gunnarsdottir K, Helgason A, Oddsson A, Halldorsson BV et al (2021) Large-scale integration of the plasma proteome with genetics and disease. Nat Genet 53:1712–1721. https://doi.org/10.1038/s41588-021-00978-wCrossRefPubMed
Boer C G, Hatzikotoulas K, Southam L, Stefánsdóttir L, Zhang Y, Coutinho de Almeida R, Wu T T, Zheng J, Hartley A, Teder-Laving M; et al. (2021) Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations. Cell 184: https://doi.org/10.1016/j.cell.2021.07.038.
23.
Tachmazidou I, Hatzikotoulas K, Southam L, Esparza-Gordillo J, Haberland V, Zheng J, Johnson T, Koprulu M, Zengini E, Steinberg J et al (2019) Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank data. Nat Genet 51:230–236. https://doi.org/10.1038/s41588-018-0327-1CrossRefPubMedPubMedCentral
24.
Xu S, Li X, Zhang S, Qi C, Zhang Z, Ma R, Xiang L, Chen L, Zhu Y, Tang C et al (2023) Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn’s disease: a multi-omics Mendelian randomization study. BMC Med 21:179. https://doi.org/10.1186/s12916-023-02878-8CrossRefPubMedPubMedCentral
25.
Papadimitriou N, Dimou N, Tsilidis KK, Banbury B, Martin RM, Lewis SJ, Kazmi N, Robinson TM, Albanes D, Aleksandrova K et al (2020) Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis. Nat Commun 11:597. https://doi.org/10.1038/s41467-020-14389-8CrossRefPubMedCentral
Lin AC, Seeto BL, Bartoszko JM, Khoury MA, Whetstone H, Ho L, Hsu C, Ali SA, Alman BA (2009) Modulating hedgehog signaling can attenuate the severity of osteoarthritis. Nat Med 15:1421–1425. https://doi.org/10.1038/nm.2055CrossRefPubMed
32.
Catheline SE, Hoak D, Chang M, Ketz JP, Hilton MJ, Zuscik MJ, Jonason JH (2019) Chondrocyte-Specific RUNX2 Overexpression Accelerates Post-traumatic Osteoarthritis Progression in Adult Mice. J Bone Miner Res 34:1676–1689. https://doi.org/10.1002/jbmr.3737CrossRefPubMed
Kammerer S, Burns-Hamuro LL, Ma Y, Hamon SC, Canaves JM, Shi MM, Nelson MR, Sing CF, Cantor CR, Taylor SS et al (2003) Amino acid variant in the kinase binding domain of dual-specific A kinase-anchoring protein 2: a disease susceptibility polymorphism. Proc Natl Acad Sci U S A 100:4066–4071CrossRefPubMedPubMedCentral
35.
Tingley WG, Pawlikowska L, Zaroff JG, Kim T, Nguyen T, Young SG, Vranizan K, Kwok P-Y, Whooley MA, Conklin BR (2007) Gene-trapped mouse embryonic stem cell-derived cardiac myocytes and human genetics implicate AKAP10 in heart rhythm regulation. Proc Natl Acad Sci U S A 104:8461–8466CrossRefPubMedPubMedCentral
36.
Wirtenberger M, Schmutzhard J, Hemminki K, Meindl A, Sutter C, Schmutzler RK, Wappenschmidt B, Kiechle M, Arnold N, Weber BHF et al (2007) The functional genetic variant Ile646Val located in the kinase binding domain of the A-kinase anchoring protein 10 is associated with familial breast cancer. Carcinogenesis 28:423–426CrossRefPubMed
37.
Langmia IM, Apalasamy YD, Suki SZ, Omar SZ, Mohamed Z (2015) Genetic association of AKAP10 gene polymorphism with reduced risk of preterm birth. J Perinatol 35:700–704. https://doi.org/10.1038/jp.2015.68CrossRefPubMed
Teng P, Liu Y, Dai Y, Zhang H, Liu W-T, Hu J (2019) Nicotine Attenuates Osteoarthritis Pain and Matrix Metalloproteinase-9 Expression via the α7 Nicotinic Acetylcholine Receptor. J Immunol 203:485–492. https://doi.org/10.4049/jimmunol.1801513CrossRefPubMed
Thangaraj G, Manakov V, Cucu A, Fournier C, Layer PG (2016) Inflammatory effects of TNFα are counteracted by X-ray irradiation and AChE inhibition in mouse micromass cultures. Chem Biol Interact 259:313–318. https://doi.org/10.1016/j.cbi.2016.03.027CrossRefPubMed
43.
Kim S-H, Serezani CH, Okunishi K, Zaslona Z, Aronoff DM, Peters-Golden M (2011) Distinct protein kinase A anchoring proteins direct prostaglandin E2 modulation of Toll-like receptor signaling in alveolar macrophages. J Biol Chem 286:8875–8883. https://doi.org/10.1074/jbc.M110.187815CrossRefPubMedPubMedCentral
44.
Jiang H, Ji P, Shang X, Zhou Y (2023) Connection between Osteoarthritis and Nitric Oxide: From Pathophysiology to Therapeutic Target. Molecules 28: https://doi.org/10.3390/molecules28041683.
Zhen G, Wen C, Jia X, Li Y, Crane JL, Mears SC, Askin FB, Frassica FJ, Chang W, Yao J et al (2013) Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 19:704–712. https://doi.org/10.1038/nm.3143CrossRefPubMedPubMedCentral
48.
Cui Z, Wu H, Xiao Y, Xu T, Jia J, Lin H, Lin R, Chen K, Lin Y, Li K et al (2022) Endothelial PDGF-BB/PDGFR-β signaling promotes osteoarthritis by enhancing angiogenesis-dependent abnormal subchondral bone formation. Bone Res 10:58. https://doi.org/10.1038/s41413-022-00229-6CrossRefPubMedPubMedCentral
49.
MacIntyre I, Zaidi M, Alam AS, Datta HK, Moonga BS, Lidbury PS, Hecker M, Vane JR (1991) Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci U S A 88:2936–2940CrossRefPubMedPubMedCentral
Löwik CW, Nibbering PH, van de Ruit M, Papapoulos SE (1994) Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. J Clin Invest 93:1465–1472CrossRefPubMedPubMedCentral
52.
Damoulis PD, Hauschka PV (1994) Cytokines induce nitric oxide production in mouse osteoblasts. Biochem Biophys Res Commun 201:924–931CrossRefPubMed
53.
Ralston SH, Todd D, Helfrich M, Benjamin N, Grabowski PS (1994) Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 135:330–336CrossRefPubMed
54.
Liu C, Li X, Lu B (2016) The Immp2l mutation causes age-dependent degeneration of cerebellar granule neurons prevented by antioxidant treatment. Aging Cell 15:167–176. https://doi.org/10.1111/acel.12426CrossRefPubMed
55.
He Q, Gu L, Lin Q, Ma Y, Liu C, Pei X, Li P A, Yang Y (2020) The Immp2l Mutation Causes Ovarian Aging Through ROS-Wnt/β-Catenin-Estrogen Pathway: Preventive Effect of Melatonin. Endocrinology 161, https://doi.org/10.1210/endocr/bqaa119.
56.
Zhang Y, Liu Y, Zarrei M, Tong W, Dong R, Wang Y, Zhang H, Yang X, MacDonald J R, Uddin M; et al. (2018) Association of IMMP2L deletions with autism spectrum disorder: A trio family study and meta-analysis. Am J Med Genet B Neuropsychiatr Genet 177: https://doi.org/10.1002/ajmg.b.32608.
57.
Lawther A J, Zieba J, Fang Z, Furlong T M, Conn I, Govindaraju H, Choong L L Y, Turner N, Siddiqui K S, Bridge W; et al. (2023) Antioxidant Behavioural Phenotype in the Immp2l Gene Knock-Out Mouse. Genes (Basel) 14: https://doi.org/10.3390/genes14091717.
58.
Zengini E, Hatzikotoulas K, Tachmazidou I, Steinberg J, Hartwig FP, Southam L, Hackinger S, Boer CG, Styrkarsdottir U, Gilly A et al (2018) Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis. Nat Genet 50:549–558. https://doi.org/10.1038/s41588-018-0079-yCrossRefPubMedPubMedCentral
59.
Zeggini E, Panoutsopoulou K, Southam L, Rayner NW, Day-Williams AG, Lopes MC, Boraska V, Esko T, Evangelou E, Hoffman A et al (2012) Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet 380:815–823. https://doi.org/10.1016/S0140-6736(12)60681-3CrossRefPubMed
Sowohl bei der zielgerichteten Behandlung als auch der Immuntherapie von resezierbaren Karzinomen des Magens und des gastroösophagealen Übergangs gibt es neue Daten. Ein Highlight: Die Ergebnisse zum Gesamtüberleben der Phase-III-Studie MATTERHORN.
Das sogenannte Beißzangen-Impingement des Hüftgelenks war in einer großen Kohortenstudie mit einem signifikant höheren Risiko für eine spätere Coxarthrose assoziiert – allerdings nur dann, wenn ein bestimmter Wert beim CE-Winkel überschritten wurde.
Das Ergebnis des fäkalen immunochemischen Tests auf Blut im Stuhl wird üblicherweise qualitativ als positiv oder negativ interpretiert. Ob sich mit einer quantitativen Auswertung das Risiko näher differenzieren lässt, ist in einer Studie untersucht worden.
Brustkrebs ist die häufigste Krebserkrankung bei Frauen. Mit dem Mammografie-Screening können Tumoren potenziell früh erkannt werden – allerdings nehmen es viele Patientinnen nicht in Anspruch. Wie kann man sie besser motivieren?
